Original Research
Published on 06 May 2021
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
in Thoracic Oncology
![Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer](https://www.frontiersin.org/files/myhome article library/602924/602924_Thumb_400.jpg)
- 3,717 views
- 5 citations
Original Research
Published on 06 May 2021
in Thoracic Oncology
Original Research
Published on 04 May 2021
in Thoracic Oncology
Review
Published on 04 May 2021
in Thoracic Oncology
Review
Published on 03 May 2021
in Thoracic Oncology
Original Research
Published on 30 Apr 2021
in Thoracic Oncology
Original Research
Published on 29 Apr 2021
in Thoracic Oncology
Original Research
Published on 29 Apr 2021
in Thoracic Oncology
Systematic Review
Published on 29 Apr 2021
in Thoracic Oncology
Original Research
Published on 28 Apr 2021
in Thoracic Oncology
Original Research
Published on 28 Apr 2021
in Thoracic Oncology
Original Research
Published on 27 Apr 2021
in Thoracic Oncology
Original Research
Published on 27 Apr 2021
in Thoracic Oncology
Original Research
Published on 27 Apr 2021
in Thoracic Oncology
Original Research
Published on 26 Apr 2021
in Thoracic Oncology
Original Research
Published on 26 Apr 2021
in Thoracic Oncology
Case Report
Published on 26 Apr 2021
in Thoracic Oncology